Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection

doi:10.3748/wjg.v12.i44.7118

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 44

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3234)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series.

Item

Count

PDF

367

HTML

2604

Figures (1-5)

263

Sum=3234

Nov 28, 2006 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (20)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Nov 28, 2006; 12(44): 7118-7125
Published online Nov 28, 2006. doi: 10.3748/wjg.v12.i44.7118

Full Size Figure Download Figure

Figure 1 Cloning of the soluble form of mouse Flt3-L containing the leader and the extracellular domain into a mammalian expression vector with CMV-promoter and RSV-enhancer. The C-terminus was tagged with a 6xHis. The soluble form of mFlt3-L is fully active.

Citation: Encke J, Bernardin J, Geib J, Barbakadze G, Bujdoso R, Stremmel W. Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection. World J Gastroenterol 2006; 12(44): 7118-7125
URL: https://www.wjgnet.com/1007-9327/full/v12/i44/7118.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i44.7118